AQR Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-50,323
| Closed | -$2.64M | – | 2315 |
|
|
2020
Q3 | $2.64M | Sell |
50,323
-48,082
| -49% | -$1.99M | ﹤0.01% | 991 |
|
|
2020
Q2 | $3.27M | Sell |
98,405
-5,738
| -6% | -$183K | 0.01% | 944 |
|
|
2020
Q1 | $2.83M | Buy |
104,143
+87,211
| +515% | +$2.43M | ﹤0.01% | 962 |
|
|
2019
Q4 | $334K | Buy |
+16,932
| New | +$271K | ﹤0.01% | 1885 |
|
|
2019
Q2 | – | Sell |
-201,526
| Closed | -$2.93M | – | 2239 |
|
|
2019
Q1 | $2.93M | Sell |
201,526
-144,802
| -42% | -$1.85M | ﹤0.01% | 1182 |
|
|
2018
Q4 | $3.82M | Buy |
346,328
+323,107
| +1,391% | +$4.5M | ﹤0.01% | 1029 |
|
|
2018
Q3 | $611K | Sell |
23,221
-7,066
| -23% | -$191K | ﹤0.01% | 1885 |
|
|
2018
Q2 | $619K | Sell |
30,287
-64,196
| -68% | -$1.38M | ﹤0.01% | 1910 |
|
|
2018
Q1 | $1.72M | Sell |
94,483
-107,847
| -53% | -$1.8M | ﹤0.01% | 1426 |
|
|
2017
Q4 | $2.82M | Sell |
202,330
-71,416
| -26% | -$965K | ﹤0.01% | 1229 |
|
|
2017
Q3 | $5.07M | Buy |
273,746
+169,734
| +163% | +$2.84M | 0.01% | 1013 |
|
|
2017
Q2 | $1.76M | Buy |
104,012
+63,618
| +157% | +$968K | ﹤0.01% | 1441 |
|
|
2017
Q1 | $539K | Buy |
+40,394
| New | +$633K | ﹤0.01% | 1865 |
|
|
2016
Q2 | – | Sell |
-56,048
| Closed | -$518K | – | 2293 |
|
|
2016
Q1 | $518K | Sell |
56,048
-177,437
| -76% | -$1.91M | ﹤0.01% | 1827 |
|
|
2015
Q4 | $3.46M | Buy |
233,485
+10,792
| +5% | +$181K | 0.01% | 1027 |
|
|
2015
Q3 | $3.65M | Buy |
222,693
+20,132
| +10% | +$412K | 0.01% | 906 |
|
|
2015
Q2 | $4.62M | Buy |
202,561
+76,708
| +61% | +$1.53M | 0.01% | 864 |
|
|
2015
Q1 | $1.91M | Sell |
125,853
-900
| -0.7% | -$11.7K | ﹤0.01% | 1127 |
|
|
2014
Q4 | $1.53M | Sell |
126,753
-85,447
| -40% | -$977K | ﹤0.01% | 1429 |
|
|
2014
Q3 | $2.41M | Sell |
212,200
-184,900
| -47% | -$2.11M | 0.01% | 1165 |
|
|
2014
Q2 | $4.8M | Sell |
397,100
-20,100
| -5% | -$237K | 0.01% | 920 |
|
|
2014
Q1 | $4.86M | Buy |
417,200
+191,700
| +85% | +$3.25M | 0.01% | 867 |
|
|
2013
Q4 | $3.99M | Sell |
225,500
-78,300
| -26% | -$1.32M | 0.01% | 977 |
|
|
2013
Q3 | $4.37M | Sell |
303,800
-212,284
| -41% | -$3.25M | 0.02% | 870 |
|
|
2013
Q2 | $7.77M | Buy |
+516,084
| New | +$6.81M | 0.03% | 666 |
|
AQR Capital Management's MNTA Position: Q4 2020 in Review
AQR Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 50,323 shares — an estimated $2.64M sold.
AQR Capital Management first reported a position in MNTA in Q2 2013 and held it in 25 quarters. The position peaked at $7.77M in Q2 2013. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- AQR Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- AQR Capital Management sold 50,323 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.64M.
- AQR Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
- AQR Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $7.77M in Q2 2013.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.